Diagnostic and Interventional Cardiology (DAIC) continues to evolve with this ever-changing market to help keep you, our ...
Cardiovascular Clinical Studies
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
June 24, 2022 — Henry Ford Health was part of a multi-institutional heart failure study that was launched and executed ...
June 24, 2022
June 22, 2022— Researchers at The Ohio State University Wexner Medical Center and College of Medicine have developed a ...
June 22, 2022
June 21, 2022 — Renibus Therapeutics (“Renibus”), a clinical-stage biotech company focusing on the prevention and ...
June 21, 2022
June 20, 2022 — Clinical trials of new gel treatments for stroke should be delayed until technology used in the tests is ...
June 20, 2022
June 17, 2022 — A multidisciplinary team of robotics and electronic systems engineers working with cardiologists and ...
June 17, 2022
June 13, 2022 — Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that ...
June 13, 2022
June 13, 2022 — Royal Philips announced the latest results from the Tack Optimized Balloon Angioplasty (TOBA) II below ...
June 13, 2022
June 10, 2022 — Individuals with diabetes display a substantially increased risk of disease in left-sided heart valves c ...
June 10, 2022
June 9, 2022 — Holes help make sponges and English muffins useful (and, in the case of the latter, delicious). Without ...
June 09, 2022
June 8, 2022 — The first patient has been enrolled in the FDA IDE BTK (Below-the-Knee) SELUTION4BTK clinical trial ...
June 08, 2022
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of May ...
June 01, 2022
June 1, 2022 — Biofourmis, a Boston-based global leader in virtual care and digital medicine, announced that its ...
June 01, 2022
May 31, 2022 — Findings from the XARELTO (rivaroxaban) Phase 3 COMPASS Long-Term Open Label Extension (LTOLE) study and ...
May 31, 2022
May 31, 2022 — Vectorious Medical Technologies Ltd., an innovator in implantable hemodynamic monitoring in heart failure ...
May 31, 2022